R&D
Through innovative R&D in nanomedicine, we seek to restore freedom, happiness, and the ability to live fully to those affected by cancer.
-
Oncology Nanomedicine
The formulation is engineered for biocompatibility and biodegradability and designed to eliminate side effects caused by the toxicity of conventional anticancer drugs, with no adverse effects related to treatment observed at the established NOAELs in completed preclinical tests.
-
PatentsOnselex has built a broad intellectual property portfolio covering its nanoparticle platform and potential applications.
PIPELINE
Onselex is expanding its pipeline by developing innovative and effective new drugs.
- 2026.08.15 Executive Summary
- 2026.07.30 Onselex Presentation
- 2021.06.15 Onselex Pharmaceuticals - Nanomedicine Platform Overview
- 2022.11.02 Onselex Welcomes Two Distinguished Medical Innovators to its Clinical Advisory Board
- 2024.04.14 An article from the Let’s Win Pancreatic Cancer Foundation about Onselex.
- 2024.04.14 An article from the Let’s Win Pancreatic Cancer Foundation about Onselex ONX-1006.
- 2023.10.09 Onselex executive summary has been posted in the releases
- 2022.11.02 Onselex Welcomes Two Distinguished Medical Innovators to its Clinical Advisory Board
- 2021.06.15 Onselex promotional video has been posted in the press releases ( please watch)
하단영역
Phone: +1-917-994-1228 E-mail: CureCancer@OnSelex.com
Copyright © Onselex Pharmaceuticals Inc. All Rights Reserved.
